These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5422275)

  • 21. The pharmacist's responsibility to determine limits to prescribing authority.
    Fink JL; McDaniel PA; Waite WW
    Am Pharm; 1984 Oct; NS24(10):74-5. PubMed ID: 6496307
    [No Abstract]   [Full Text] [Related]  

  • 22. Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy.
    Carmichael JM; O'Connell MB; Devine B; Kelly HW; Ereshefsky L; Linn WD; Stimmel GL
    Pharmacotherapy; 1997; 17(5):1050-61. PubMed ID: 9324201
    [No Abstract]   [Full Text] [Related]  

  • 23. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1993 Nov; 50(11):2386-98. PubMed ID: 8266973
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug product selection and the law.
    Fink JL
    Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of Canadian pharmacist involvement in adverse drug reaction reporting.
    Taras-Zasowski KM; Einarson TR
    Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist's responsibility for providing drug information to be used for questionable purposes.
    Uretsky SD; Kelly WN; Veatch RM
    Am J Hosp Pharm; 1992 Jul; 49(7):1725; discussion 1725-30. PubMed ID: 1621731
    [No Abstract]   [Full Text] [Related]  

  • 27. ASHP statement on the pharmacist's role in clinical pharmacokinetic monitoring.
    Am J Health Syst Pharm; 1998 Aug; 55(16):1726-7. PubMed ID: 9740913
    [No Abstract]   [Full Text] [Related]  

  • 28. ASHP guidelines on the pharmacist's role in providing drug information.
    Ghaibi S; Ipema H; Gabay M;
    Am J Health Syst Pharm; 2015 Apr; 72(7):573-7. PubMed ID: 25788512
    [No Abstract]   [Full Text] [Related]  

  • 29. To substitute or not to substitute.
    Bader AS
    Del Med J; 1975 Mar; 47(3):124. PubMed ID: 1116634
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of a pharmacist in improving rational drug therapy as part of the patient care team.
    Smith WE
    Ann Pharmacother; 2007 Feb; 41(2):330-5. PubMed ID: 17299008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The new pharmaceutical manual and citizens' rights. The viewpoint of the Italian Society of Hospital Pharmacy].
    Martini N
    Recenti Prog Med; 1994 May; 85(5):267-8. PubMed ID: 8023003
    [No Abstract]   [Full Text] [Related]  

  • 32. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse.
    Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674
    [No Abstract]   [Full Text] [Related]  

  • 33. ASHP Statement on the Pharmacist's Role in Substance Abuse Prevention, Education, and Assistance.
    Am J Health Syst Pharm; 2016 May; 73(9):e267-70. PubMed ID: 27099335
    [No Abstract]   [Full Text] [Related]  

  • 34. ASHP statement on the pharmacist's role in infection control.
    Am J Health Syst Pharm; 1998 Aug; 55(16):1724-6. PubMed ID: 9740912
    [No Abstract]   [Full Text] [Related]  

  • 35. Challenges to a border state pharmacy association.
    Wagenknecht L
    Manag Care; 2004 Mar; 13(3 Suppl):36-7. PubMed ID: 15074170
    [No Abstract]   [Full Text] [Related]  

  • 36. A pharmacist model of perceived responsibility for drug therapy outcomes.
    Planas LG; Kimberlin CL; Segal R; Brushwood DB; Hepler CD; Schlenker BR
    Soc Sci Med; 2005 May; 60(10):2393-403. PubMed ID: 15748686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the pharmacist's prerogatives.
    Davidson WA
    Am J Pharm Sci Support Public Health; 1973; 145(2):48-50. PubMed ID: 4703503
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contribution of pharmacists to the optimization of therapy--a retrospective view].
    Froböse HH
    Pharmazie; 1983 Sep; 38(9):618-20. PubMed ID: 6359179
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacy and generic substitution of antiepileptic drugs: missing in action?
    Welty TE
    Ann Pharmacother; 2007 Jun; 41(6):1065-8. PubMed ID: 17504833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of clinical pharmacists on drug-related problems and clinical outcomes.
    Viktil KK; Blix HS
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):275-80. PubMed ID: 18248511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.